Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Ayodele Alaiya, MPH, MBBS, PhD, Mahmoud Aljurf, MD, Zakia Shinwari, MSc, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP, Tarek Owaidah, MD FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Riad Elfakih, MD, Saud Alhayli, MD, Shahrukh Hashmi, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD

Blood (2018) 132 (Supplement 1): 5434.

https://doi.org/10.1182/blood-2018-99-118754

Published: 2018

Journal Articles

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

Ayodele Alaiya, MBBS,MPH,PhDFRCPath, Zakia Shinwari, MSc, Hazza Alzahrani, MD, Tarek Owaidah, MD, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Randa M Alnounou, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Raid El Fakih, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Abdulaziz Alfraih, MD, Hashmi Shahrukh, MD, Majed Dasouki, MD, Naeem A. Chaudhri, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Mahmoud Aljurf

Blood (2017) 130 (Supplement 1): 2465.

https://doi.org/10.1182/blood.V130.Suppl_1.2465.2465

Published: 2017

Journal Articles

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

Ayodele Alaiya, MPH,MBBS,PhD FRCPath, Hazza A Alzahrani, MD, Zakia Shinwari, MSc, Tarek Owaidah, MD FRCPA, Fahad Al Mohareb, MD, Fahad Al Sharif, MD, Randa Al Nounou, MD, Naeem A. Chaudhri, MD FACP, Ghuzayel Aldawsari, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Alfraih, MD, Syed Osman Ahmed, MD MRCP, FRCPath, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 2414.

https://doi.org/10.1182/blood.V126.23.2414.2414

Published: 2015

Journal Articles

Proteomics–Based Approach Predicts Molecular Response and Stratifies Responders to Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) Patients

Ayodele Alaiya, MD MPH, PhD, Naeem A. Chaudhri, MD FACP, Hafiz Malhan, MD, Tarek Owaidah, MD FRCPA, Zakia Shinwari, MSc, Jonathan Fox, PhD, Fahad Alsharif, MD, Said Mohamed, MD, Walid Rasheed, MD, Osman Ahmed Syed, MD FRCPA, Mahmoud D. Aljurf, MD

Blood (2014) 124 (21): 4556.

https://doi.org/10.1182/blood.V124.21.4556.4556

Published: 2014

Journal Articles

Expression Proteomics As Surrogate Biomarkers For Early Treatment Response In Chronic Myeloid Leukemia (CML) Patients

Ayodele Alaiya, MD, MPH, PhD, Naeem Chaudhri, MD, Tarek Owaidah, MD, FRCPA, Jonathan Fox, PhD, Zakia Shinwari, MSc, Eman Barhoush, BSc, Fahad Alsharif, MD, Said Y Mohamed, MD, Walid Rasheed, M.D., Feras Alfraih, MD, Mahmoud Aljurf, M.D.

Blood (2013) 122 (21): 4016.

https://doi.org/10.1182/blood.V122.21.4016.4016

Published: 2013

NARROW

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

Proteomics–Based Approach Predicts Molecular Response and Stratifies Responders to Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) Patients

Expression Proteomics As Surrogate Biomarkers For Early Treatment Response In Chronic Myeloid Leukemia (CML) Patients

Email alerts

ASH Publications

American Society of Hematology

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

Proteomics–Based Approach Predicts Molecular Response and Stratifies Responders to Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) Patients

Expression Proteomics As Surrogate Biomarkers For Early Treatment Response In Chronic Myeloid Leukemia (CML) Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only